clinical trial · NCT06649006
Study to Investigate Intravenous Blinatumomab in Japanese Adult Participants With Newly Diagnosed Philadelphia-negative B-precursor Acute Lymphoblastic Leukemia (B-ALL)
B-precursor Acute Lymphoblastic LeukemiaBlinatumomab
brief summary
The main objective of the study is to evaluate safety and tolerability of blinatumomab in adult Japanese participants with newly diagnosed B-ALL.
started
Jan 8, 2025
primary completion
Jul 30, 2025
completion
Dec 4, 2025
last updated
May 13, 2026
official title
A Phase 1b Open-label Study to Investigate Safety, Tolerability and Pharmacokinetics of Intravenous Blinatumomab in Japanese Adult Subjects With Newly Diagnosed Philadelphia-negative B-precursor Acute Lymphoblastic Leukemia (B-ALL)
sourced from ClinicalTrials.gov · pharmadog mirrors structured fields, not the full protocol